All News
Startups could lead the revolution in preventative healthcare
Sushant Kumar,Founder,Genefitletics,discusses how ORAONCO uses next-gen sequencing and machine learning to detect oral cancer years before symptoms appear,and how it aims to redefine clinical pathways
Read MoreOpinion: Science is under attack. So I’m taking RFK Jr. to court
“After losing every one of my grants — and seeing the human cost to my team, patients, and society — I knew silence was not an option,” writes Brittany Charlton.
Read MoreBeyond politics, even U.S. vaccine experts may envision fewer Covid shots in the future
For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.
Read MoreSTAT+: Chinese and Chinese-American researchers in the U.S. confront a perilous moment
Chinese and Chinese-American researchers are reassessing their futures in the U.S., potentially shifting the balance in global scientific innovation, as well as in the biopharma industry.
Read MoreAmid the Milwaukee lead crisis, a laid-off CDC scientist volunteered his expertise. It wasn’t so simple
After his job was cut, a CDC scientist volunteered to help Milwaukee respond to the lead crisis in its public schools. For now, he's in limbo.
Read MoreNursing the future
From hospitals to community settings,nurse leaders can drive measurable improvements in healthcare by combining frontline expertise with systems-level thinking
Read MorePersonalised medicine in India needs a systemic prescription
The authors highlight how India’s regulatory vacuum—rather than scientific or market limitations, is the key barrier preventing personalised medicine from becoming a viable, system-wide healthcare
Read MoreNo Causal Link Between Stimulants and Psychotic Experiences in Kids With ADHD
(MedPage Today) -- There was no evidence to support a causal relationship between a common treatment for attention deficit-hyperactivity disorder (ADHD) and psychotic experiences in children, accordi
Read MoreTrump Plan Would Tie Some Drug Prices to What Peer Nations Pay
The president announced an executive order aimed at lowering U.S. drug costs, revisiting an idea that was blocked in court during his first term.
Read MoreTrump confirms he will sign ‘most-favored nation’ executive order in bid to lower drug prices
President Trump said Sunday that he would sign an executive order to base U.S. drug prices on what other countries pay — an effort likely to be challenged in court.
Read More